Johnson & Johnson has petitioned the U.S. Supreme Court to reverse a $344 million pelvic mesh judgment for the state of California and rein in what it called a “dangerous trend” that’s generated million-dollar verdicts to attorneys general throughout the country.

The 2020 judgment against Johnson & Johnson’s Ethicon unit was among the rare decisions in a government case brought over transvaginal mesh devices, which are surgically implanted in women to treat stress urinary incontinence and pelvic organ prolapse.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]